Enterprise

Supermicro Plans $7B Raise to Fund $39B AI Server Backlog

The hardware maker will tap equity markets to purchase components for advanced AI infrastructure orders from more than 20 customers.

Omega Editorial· June 10, 2026· 3 min read

Supermicro targets $7 billion to fulfill AI server orders

Super Micro Computer has unveiled plans to raise $7 billion through a combination of equity and equity-linked offerings, directing the capital toward component purchases for its advanced AI server systems. The financing comes as the company works to fulfill approximately $39 billion in orders received from more than 20 customers in recent weeks, according to details first reported by Verdict.

The fundraising structure includes $5 billion in underwritten public offerings split between $3.75 billion in depositary shares and $1.25 billion in common stock. Each offering includes a 30-day greenshoe option for underwriters to purchase additional shares, and neither offering is contingent on the other's completion.

Supermicro also plans to establish an at-the-market offering program for common stock that could generate up to $2 billion, though this component won't launch before the third quarter of 2026. J.P. Morgan, Goldman Sachs, and Citigroup will manage the ATM program.

Why it matters

The scale of Supermicro's order backlog—$39 billion from just over 20 customers—provides concrete evidence of enterprise AI infrastructure spending accelerating beyond hyperscaler deployments. The company's need to raise capital specifically for component procurement also highlights supply chain constraints in the AI hardware market, where demand is outpacing manufacturers' ability to secure parts at the pace required. For technology leaders evaluating AI infrastructure investments, Supermicro's capital raise signals both robust market demand and potential delivery timeline pressures across the sector.

Capital allocation and market response

The company stated that proceeds will primarily fund acquisition of components for its advanced AI servers, including its Data Center Building Block Solutions product line. Supermicro indicated it may also allocate portions of the capital to debt repayment, working capital, and capital expenditures.

Investors reacted negatively to the equity dilution, with shares declining 8% in extended trading following the announcement.

Recent performance and outlook

Supermicro's third quarter fiscal 2026 results showed net sales of $10.2 billion, down from $12.7 billion in the prior quarter but up substantially from $4.6 billion in the year-ago period. Net income reached $483 million compared to $401 million in Q2 FY26 and $109 million in Q3 FY25.

For the fourth quarter ending June 30, 2026, the company projects net sales between $11.0 billion and $12.5 billion. GAAP net income per diluted share is expected in the range of $0.53 to $0.67, while non-GAAP earnings per share are forecast between $0.65 and $0.79.

Earlier this month, Supermicro announced a collaboration with Arm to develop AI-centric solutions using Arm AGI CPUs, targeting enhanced compute performance for agentic AI applications within enterprise data center power and space constraints.

These details were originally reported by Verdict, a GlobalData brand.

#supermicro#ai infrastructure#equity financing#ai servers#data center#enterprise ai

This is an original analysis by the Omega editorial team. Source reporting: AI Watch.

Want systems like this working for your business?

Book a Call

More in Enterprise

Enterprise· 4 min read

Dr. Martens Rebuilt Customer Service From Scratch After Years of Decline

The footwear brand consolidated fragmented systems across regions onto Salesforce and AWS, reversing a three-year slide in customer satisfaction within months.

Via Automation Watch · Sep 24, 2026
Enterprise· 4 min read

AI Coding Tools Added $942M to Hospital Bills Without Care Changes

Blue Cross Blue Shield Association analysis finds hospitals using automation to classify more cases as complex, driving up costs with no documented increase in treatment intensity.

Via AI Watch · Sep 24, 2026
Enterprise· 4 min read

AI Clinical Trial Endpoints Fail at Scale Without Data Harmonization

Analysis of over one million patient screenings reveals that AI validation in single sites masks critical performance drift across multi-site deployments.

Via AI Watch · Sep 24, 2026